USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-15 обновлены отчеты компании VRTX: 202320222021
Vertex Pharmaceuticals Incorporated logo
Vertex Pharmaceuticals Incorporated VRTX
$ 402.5 0.35%

Vertex Pharmaceuticals Incorporated Мультипликаторы 2011-2024 | VRTX

Мультипликаторы по годам Vertex Pharmaceuticals Incorporated

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

30.3 22.9 24.2 22.6 50.2 22.7 157.3 -184.3 -39.4 -35.1 -41.5 -88.4 240.7

P/S

11.1 8.5 7.5 9.9 14.2 15.6 16.7 12.1 21.2 44.7 15.2 6.2 5.0

EPS

14.1 13.0 9.1 10.4 4.6 8.2 1.1 -0.5 -2.3 -3.1 -2.0 -0.5 0.1

EV (Enterprise Value)

105 млрд 69.8 млрд 53.1 млрд 58.5 млрд 58.3 млрд 46.7 млрд 41.3 млрд 21 млрд 22.6 млрд 26.5 млрд 18.9 млрд 10.5 млрд 7.88 млрд

EBITDA per Share

15.6 17.4 11.3 11.4 5.1 2.9 1.83 0.297 -1.67 -2.46 -0.672 0.2 1.25

EV/EBITDA

18.2 18.1 42.8 61.0 87.6 276.3 -53.4 -44.2 -118.5 221.3 27.4

PEG

0.63 0.37 0.16 0.17 -1.13 0.03 0.48 -2.3 -1.49 0.6 0.14 0.2 2.32

P/B

6.2 5.5 5.6 7.1 9.7 10.7 20.3 15.4 20.0 23.6 13.6 7.9 7.4

P/CF

31.0 18.4 21.4 18.9 39.6 40.5 70.8 115.0 -53.3 -45.9 -179.4 48.1 144.8

ROE %

20.59 23.88 23.19 31.22 19.34 47.28 12.90 -8.37 -50.87 -67.38 -32.81 -8.95 3.06

ROA %

15.92 18.30 17.44 23.07 14.15 33.57 7.43 -3.87 -22.26 -31.63 -19.19 -3.88 1.34

ROCE %

21.80 30.96 27.55 32.88 17.21 12.95 14.34 0.53 -23.32 -32.62 -10.38 0.18 12.24

Current Ratio

4.4 4.3 4.0 3.8 3.6 3.4 3.3 2.3 2.8 4.2 4.0 3.7 3.4

DSO

55.6 52.7 48.7 44.7 55.5 57.1 56.4 43.8 66.9 56.6 25.8 34.2 47.4

DIO

173.4 137.5 127.9 111.1 111.6 110.8 148.4 134.6 167.7 184.6 39.6 39.7 509.7

DPO

96.7 84.3 70.7 60.2 58.4 98.9 98.2 106.6 219.7 426.1 138.2 132.1 338.4

Операционный цикл

229.0 190.2 176.7 155.8 167.2 167.9 204.8 178.4 234.6 241.3 65.4 74.0 557.1

Финансовый цикл

132.3 105.9 106.0 95.6 108.8 69.0 106.6 71.8 14.9 -184.8 -72.8 -58.1 218.7

Все данные представлены в валюте USD

Мультипликаторы поквартально Vertex Pharmaceuticals Incorporated

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

4.01 3.55 2.72 - 3.63 3.17 2.99 - 3.3 0.26 2.52 2.32 2.56 3.22 2.32 2.26 0.22 1.04 1.05 6.08 0.51 0.82 0.83 0.4 -0.41 0.07 1.01 0.13 -0.16 -0.26 -0.17 -0.3 -0.39 -0.78 -0.83 -0.74 -0.72 -0.68 -1 0.19 -0.54 -0.26 -1.43 -0.35 -0.27 -0.31 0.44 0.76 1.06 -0.85 -0.87

EBITDA per Share

- - 3.18 - 4.82 4.32 4.22 - 4.44 -0.15 3.53 2.87 2.89 2.97 2.88 2.14 0.7 1.27 1.19 0.5 1.02 0.82 0.57 0.5 -1.12 0.33 1.16 0.16 0.11 0.14 0.01 -0.22 -0.1 -0.58 -0.65 -0.64 -0.4 -0.64 -0.86 -0.04 -0.4 -0.12 -1.94 -0.36 0.12 0.03 0.48 1.08 1.17 -0.73 -0.75

ROE %

24.18 25.05 25.92 20.92 29.86 31.66 25.59 16.94 23.89 22.64 31.55 31.22 33.84 27.11 22.74 20.22 45.59 49.08 51.52 55.87 25.87 16.36 9.53 12.99 10.87 12.59 6.12 -9.69 -20.38 -27.15 -41.66 -59.19 -67.78 -73.47 -68.21 -68.70 -49.00 -42.34 -31.72 -32.81 -43.70 -40.30 -42.59 -10.71 17.07 50.93 35.31 3.76 28.10 -22.12 -22.38

ROA %

18.52 19.33 20.17 16.26 23.01 18.85 19.40 12.69 17.83 16.76 23.34 23.07 24.94 19.96 16.05 14.15 31.96 33.33 33.44 33.57 11.59 6.62 3.81 7.43 5.73 7.29 4.56 -3.87 -7.96 -10.42 -15.75 -22.27 -26.88 -30.36 -29.63 -31.63 -22.16 -20.23 -15.86 -19.19 -23.86 -20.59 -20.48 -3.88 6.08 18.19 12.65 1.34 10.03 -7.90 -7.99

ROCE %

26.97 29.33 31.96 27.46 38.53 40.94 31.26 20.54 29.12 25.80 34.48 32.88 33.36 27.25 24.31 20.57 14.39 19.83 20.94 21.76 25.08 1.93 -1.91 6.08 3.30 17.76 15.45 0.86 -8.28 -14.11 -32.61 -49.67 -58.25 -64.03 -62.61 -64.41 -50.88 -46.76 -33.43 -44.97 -51.97 -42.97 -40.58 0.23 36.44 63.96 43.96 14.47 27.41 -21.08 -20.32

Current Ratio

4.2 4.2 4.2 4.3 4.5 - 4.3 4.0 4.1 4.0 3.9 3.8 3.8 3.8 3.8 3.7 3.7 3.7 3.7 3.5 3.5 3.5 3.5 2.4 2.4 2.4 2.4 1.9 1.9 1.9 1.9 1.8 1.8 1.8 1.8 1.9 1.9 1.9 1.9 2.4 2.4 2.4 2.4 1.8 1.8 1.8 1.8 1.8 1.8 1.8 1.8

DSO

56.9 56.8 57.4 - 27.1 26.9 52.9 - 46.7 48.5 49.3 49.6 52.5 53.0 45.7 40.9 60.9 61.4 55.5 43.0 47.6 49.7 49.2 39.4 44.4 47.2 30.8 39.9 44.3 42.5 43.0 38.0 51.8 97.6 83.5 48.0 38.7 50.1 62.2 22.2 35.2 25.1 31.8 39.1 38.9 31.2 33.9 29.7 25.4 146.1 -

DIO

185.0 168.3 170.2 - 61.2 59.1 128.4 - 126.4 124.2 137.5 126.2 137.6 138.8 125.9 82.6 115.9 112.6 140.0 92.8 102.0 108.7 150.5 121.4 140.0 143.3 183.9 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

105.8 101.5 107.2 - 20.0 30.2 68.4 - 49.3 51.1 67.1 69.7 76.0 76.7 68.2 43.2 60.6 58.9 95.3 82.8 91.0 97.0 117.8 80.3 92.7 94.8 131.5 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

241.8 225.1 227.7 - 88.3 85.9 181.3 - 173.1 172.7 186.8 175.8 190.1 191.8 171.6 123.5 176.7 174.0 195.5 135.8 149.7 158.4 199.7 160.8 184.4 190.5 214.7 39.9 44.3 42.5 43.0 38.0 51.8 97.6 83.5 48.0 38.7 50.1 62.2 22.2 35.2 25.1 31.8 39.1 38.9 31.2 33.9 29.7 25.4 146.1 -

Финансовый цикл

136.1 123.7 120.5 - 68.3 55.7 112.9 - 123.8 121.6 119.7 106.1 114.1 115.1 103.5 80.3 116.1 115.1 100.2 52.9 58.6 61.4 81.8 80.5 91.8 95.7 83.2 39.9 44.3 42.5 43.0 38.0 51.8 97.6 83.5 48.0 38.7 50.1 62.2 22.2 35.2 25.1 31.8 39.1 38.9 31.2 33.9 29.7 25.4 146.1 -

Все данные представлены в валюте USD